Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 2Cognitive Dysfunction 2Brain Neoplasms 2Stroke 1Sarcoma 1Radiation Injuries 1Parkinson Disease 1Osteosarcoma 1Medulloblastoma 1Lung Neoplasms 1Infratentorial Neoplasms 1Epilepsy 1Brain Injuries, Traumatic 1

Interventions

Doxorubicin 19Radiotherapy 10Ifosfamide 10apatinib 9anlotinib 8Cyclophosphamide 8camrelizumab 7Vincristine 5Dactinomycin 5toripalimab 3Trabectedin 3Radiation Dose Hypofractionation 3Ipilimumab 3Gemcitabine 3Etoposide 3Docetaxel 3selinexor 2ribociclib 2envafolimab 2brostallicin 2Topotecan 2Thalidomide 2Temozolomide 2Sorafenib 2Oncolytic Virotherapy 2Nivolumab 2Neoadjuvant Therapy 2Melphalan 2Magnetic Resonance Spectroscopy 2Irinotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Sarcoma × Neuropsychological Tests × Clear all
NCT02309242 2015-08-21

Long Term Neurotoxic Effects of Chemotherapy in Survivors of Bone and Soft Tissue Sarcomas. A Retrospective Study

Universitaire Ziekenhuizen KU Leuven

Phase NA Unknown
60 enrolled
Sarcoma

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡